What is the appropriate workup and management for a patient with treatment‑resistant hives likely due to urticarial vasculitis, presenting with fatigue, night sweats, and intermittent low‑grade fever of unknown cause?

Workup and Management for Treatment-Resistant Urticarial Vasculitis with Constitutional Symptoms

This patient requires immediate skin biopsy to confirm urticarial vasculitis, comprehensive laboratory evaluation to identify systemic disease (particularly autoinflammatory syndromes and connective tissue disease), and escalation beyond antihistamines to systemic immunomodulatory therapy given the presence of fever, night sweats, and fatigue.

Diagnostic Confirmation

Skin Biopsy - Essential First Step

Perform a skin biopsy of a lesion less than 24 hours old to confirm leukocytoclastic vasculitis. Urticarial vasculitis weals typically persist for days rather than the 2-24 hours seen in ordinary urticaria 1. Look specifically for small vessel vasculitis with fibrinoid deposits in perivascular and interstitial locations 2.

Key Clinical Features Supporting UV Diagnosis

• Wheal duration >24 hours (most important diagnostic feature, reported by 72% of physicians) 3
• Post-inflammatory hyperpigmentation, purpura, or ecchymotic residua 4
• Pain or burning rather than pure pruritus 4
• Constitutional symptoms (fever, malaise, arthralgia) 1

Comprehensive Laboratory Workup

Given the fever, night sweats, and fatigue, this patient requires evaluation for:

Essential Initial Tests

• Complete blood count with differential (evaluate for eosinophilia, leukocytosis)
• Erythrocyte sedimentation rate and C-reactive protein (elevated in autoinflammatory syndromes) 2
• Complement levels (C3, C4, CH50) - critical for identifying hypocomplementemic UV
• C1 esterase inhibitor level and function (if angioedema present)
• Antinuclear antibodies (screen for systemic lupus erythematosus)
• Urinalysis (assess for renal involvement) 1

Additional Testing Based on Constitutional Symptoms

The presence of recurrent fever, night sweats, and fatigue mandates evaluation for autoinflammatory syndromes 1:

• Serum protein electrophoresis and immunofixation (screen for paraproteinemia/Schnitzler syndrome in adults) 2
• Cryopyrin-associated periodic syndrome (CAPS) gene mutation analysis if hereditary autoinflammatory syndrome suspected 1
• Consider neutrophil-rich infiltrates on skin biopsy 2

Exclude Secondary Causes

• Review all medications (ACE inhibitors, NSAIDs, antibiotics)
• Screen for underlying malignancy if age-appropriate
• Evaluate for connective tissue disease (anti-dsDNA, anti-Smith antibodies if ANA positive)
• Consider infectious workup if clinically indicated 5, 6

Treatment Algorithm

Step 1: Discontinue Ineffective Antihistamines

H1-antihistamines are not effective in most patients with UV 5. While they may be continued, do not expect significant improvement and proceed immediately to immunomodulatory therapy given treatment resistance and systemic symptoms.

Step 2: Systemic Corticosteroids for Acute Control

Initiate systemic corticosteroids immediately for rapid symptom control - effective in >80% of patients with UV 5. Use pulse IV or high-dose daily oral corticosteroids for severe symptoms 1. However, prolonged corticosteroid monotherapy leads to serious adverse effects and is not sustainable 5.

Step 3: Add Steroid-Sparing Immunomodulatory Agent

For patients with severe symptoms (particularly with fever and constitutional symptoms) or hypocomplementemic UV, initiate immunomodulatory therapy concurrently with corticosteroids 7:

First-Line Steroid-Sparing Options:

• Dapsone: High efficacy for both skin and systemic symptoms; associated with long-lasting treatment-free responses 5, 6
• Hydroxychloroquine: Particularly effective if connective tissue disease suspected 7, 5
• Colchicine: Consider especially if autoinflammatory syndrome suspected 5

Second-Line Options if First-Line Fails:

• Mycophenolate mofetil: Effective for skin and systemic symptoms; long-lasting remission 5, 6
• Cyclosporine A: Can be effective but inconsistent outcomes 7, 8
• Cyclophosphamide: Reserved for severe systemic disease 5, 6

Step 4: Biologic Therapy for Refractory Cases

If conventional immunomodulatory therapy fails:

• Anti-IL-1 agents (anakinra, canakinumab): Highest success rates in recent studies, particularly for autoinflammatory presentations 7, 5, 6
• Omalizumab: Variable response (some patients achieve complete remission, others no response) 7, 5, 8
• Rituximab: High efficacy with long-lasting treatment-free responses 5, 6
• JAK inhibitors (upadacitinib): Emerging option for refractory cases 9

Critical Pitfalls to Avoid

1. Do not treat as chronic spontaneous urticaria - UV requires systemic immunomodulation, not just antihistamine escalation 4

2. Do not delay skin biopsy - this is the gold standard for diagnosis and guides appropriate therapy 3

3. Do not miss hypocomplementemic UV - requires more aggressive therapy and has worse prognosis with 5-year survival of 92% and 10-year survival of 83% 6

4. Do not ignore constitutional symptoms - fever, night sweats, and fatigue suggest autoinflammatory syndrome (Schnitzler syndrome, CAPS) or systemic disease requiring specific evaluation 1, 2

5. Do not use prolonged corticosteroid monotherapy - always add steroid-sparing agent early 5

Multidisciplinary Approach

Patients with UV and systemic symptoms require multidisciplinary care 4, 7. Consider referral to:

• Rheumatology (if connective tissue disease or vasculitis suspected)
• Allergy-Immunology (for diagnostic workup and immunomodulatory therapy guidance) 4
• Nephrology (if renal involvement present)

The combination of treatment-resistant hives with fever, night sweats, and fatigue places this patient in a high-risk category requiring aggressive diagnostic evaluation and early immunomodulatory intervention beyond standard urticaria management.